Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alopecia | 5 | 2022 | 416 | 0.970 |
Why?
|
| Panniculitis | 1 | 2020 | 45 | 0.700 |
Why?
|
| Honey | 1 | 2019 | 12 | 0.670 |
Why?
|
| Folliculitis | 1 | 2019 | 25 | 0.660 |
Why?
|
| Scalp Dermatoses | 1 | 2019 | 44 | 0.640 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2019 | 78 | 0.630 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 214 | 0.550 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2019 | 542 | 0.480 |
Why?
|
| Arthritis | 1 | 2020 | 684 | 0.480 |
Why?
|
| Pancreatitis | 1 | 2020 | 1087 | 0.440 |
Why?
|
| Skin | 5 | 2021 | 4499 | 0.400 |
Why?
|
| Skin Neoplasms | 5 | 2021 | 5860 | 0.310 |
Why?
|
| Scalp | 2 | 2019 | 390 | 0.260 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2930 | 0.230 |
Why?
|
| Lymphangitis | 1 | 2023 | 15 | 0.220 |
Why?
|
| Mycobacterium marinum | 1 | 2023 | 29 | 0.210 |
Why?
|
| Cephalexin | 1 | 2019 | 37 | 0.170 |
Why?
|
| Tinea Capitis | 1 | 2019 | 16 | 0.160 |
Why?
|
| Hair | 2 | 2022 | 508 | 0.160 |
Why?
|
| Injections, Intralesional | 1 | 2019 | 280 | 0.150 |
Why?
|
| Nail Diseases | 1 | 2018 | 54 | 0.150 |
Why?
|
| Shoulder | 2 | 2016 | 300 | 0.140 |
Why?
|
| Radiography, Abdominal | 1 | 2020 | 543 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12985 | 0.140 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 210 | 0.140 |
Why?
|
| Erythema Nodosum | 1 | 2016 | 32 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 705 | 0.130 |
Why?
|
| Graft vs Host Disease | 2 | 2019 | 3079 | 0.130 |
Why?
|
| Alopecia Areata | 1 | 2018 | 130 | 0.130 |
Why?
|
| Myofibroma | 1 | 2016 | 45 | 0.130 |
Why?
|
| Sarcoma, Kaposi | 1 | 2019 | 376 | 0.130 |
Why?
|
| Sweet Syndrome | 1 | 2016 | 56 | 0.130 |
Why?
|
| Myofibromatosis | 1 | 2015 | 27 | 0.130 |
Why?
|
| Carcinosarcoma | 1 | 2016 | 108 | 0.120 |
Why?
|
| Azathioprine | 1 | 2016 | 354 | 0.120 |
Why?
|
| Syndrome | 1 | 2020 | 3271 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2020 | 1069 | 0.110 |
Why?
|
| Pancreas | 1 | 2020 | 1698 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2019 | 2659 | 0.100 |
Why?
|
| Nevus | 1 | 2014 | 205 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1497 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2018 | 734 | 0.090 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2158 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2019 | 1084 | 0.090 |
Why?
|
| Dermatology | 1 | 2021 | 905 | 0.090 |
Why?
|
| Biopsy | 5 | 2021 | 6779 | 0.080 |
Why?
|
| Quality of Life | 2 | 2022 | 13476 | 0.080 |
Why?
|
| Carcinoma | 1 | 2019 | 2325 | 0.070 |
Why?
|
| Drug Hypersensitivity | 1 | 2016 | 903 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1880 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 1424 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7475 | 0.060 |
Why?
|
| Male | 11 | 2022 | 364154 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9244 | 0.050 |
Why?
|
| Humans | 16 | 2023 | 766812 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 2002 | 223 | 0.040 |
Why?
|
| Current Procedural Terminology | 1 | 2021 | 101 | 0.040 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.040 |
Why?
|
| Hormones | 1 | 2002 | 866 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20710 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 59939 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 1740 | 0.030 |
Why?
|
| Nevus, Spindle Cell | 1 | 2014 | 2 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2023 | 1217 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 223267 | 0.030 |
Why?
|
| Epithelioid Cells | 1 | 2014 | 61 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2019 | 9358 | 0.030 |
Why?
|
| Cicatrix | 1 | 2019 | 798 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2016 | 619 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1838 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2015 | 769 | 0.020 |
Why?
|
| Melanocytes | 1 | 2014 | 509 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 171344 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2002 | 3715 | 0.020 |
Why?
|
| Female | 7 | 2022 | 396532 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54872 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7841 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10580 | 0.010 |
Why?
|
| Infant | 2 | 2016 | 36459 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2016 | 2286 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4215 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11062 | 0.010 |
Why?
|
| Depression | 1 | 2002 | 8225 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2002 | 362 | 0.010 |
Why?
|
| Locus Coeruleus | 1 | 2002 | 241 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2002 | 898 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13642 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26309 | 0.010 |
Why?
|
| Melanoma | 1 | 2014 | 5702 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1407 | 0.010 |
Why?
|
| Amygdala | 1 | 2002 | 1375 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2002 | 2224 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65286 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 223305 | 0.000 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_